(Q48123682)

8 February 2018

title

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study. (English)

1 reference

8 February 2018

1 reference

1 reference

1 reference

6

1 reference

8 February 2018

Karl J. Friston

9

1 reference

8 February 2018

David J. Brooks

10

1 reference

8 February 2018

T Uema

2

object named as

Uema T

1 reference

8 February 2018

author name string

Rakshi JS

1

1 reference

8 February 2018

Ito K

3

1 reference

8 February 2018

Bailey DL

4

1 reference

8 February 2018

Morrish PK

5

1 reference

8 February 2018

Dagher A

7

1 reference

8 February 2018

Jenkins IH

8

1 reference

8 February 2018

language of work or name

English

0 references

publication date

1 September 1999

1 reference

8 February 2018

number of pages

14

0 references

published in

Brain

1 reference

8 February 2018

volume

122 ( Pt 9)

1 reference

8 February 2018

issue

9

1 reference

28 June 2019

page(s)

1637-1650

1 reference

8 February 2018

Compensatory bilateral changes in dopamine turnover after striatal kainate lesion

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

3D acquisition and reconstruction in positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

A convolution-subtraction scatter correction method for 3D PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Determination of plasma [18F]-6-fluorodopa during positron emission tomography: elimination and metabolism in carbidopa treated subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Plastic transformation of PET images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Comparing functional (PET) images: the assessment of significant change

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Statistical parametric maps in functional imaging: A general linear approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Dopamine visualized in the basal ganglia of living man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Dopa decarboxylase activity of the living human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Nonparametric analysis of statistic images from functional mapping experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Nigrostriatal function in humans studied with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Clinical and [18F] dopa PET findings in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Elevated dopa decarboxylase activity in living brain of patients with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: an 11C-flumazenil PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Dopamine deficiency in the cerebral cortex in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Aromatic L-amino-acid decarboxylase (DOPA decarboxylase) gene expression in dopaminergic and serotoninergic cells of the rat brainstem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.9.1637

21 January 2018

Identifiers

DOI

10.1093/BRAIN/122.9.1637

1 reference

8 February 2018

PubMed ID

10468504

1 reference

8 February 2018